Welcome! The Alzheimer's Disease Research Center (ADRC) at Mayo Clinic promotes research and education about healthy brain aging, mild cognitive impairment, Alzheimer's disease, and other related dementia disorders. For patients and families affected by Alzheimer's disease or a related dementia, the ADRC at Mayo Clinic offers education and support programs, as well as opportunities to participate in clinical trials and research discoveries.

This website is dedicated primarily to the community outreach activities of the ADRC at Mayo Clinic in Jacksonville, FL. To view the main Mayo Clinic ADRC website, click here.

Use the menu above or the tiles below to learn more and get involved in our community outreach efforts.


COVID-19 UPDATE: Mayo ADRC Research Visits & Community Outreach Events Postponed

March 16, 2020 updated May 4, 2020

In response to the COVID-19 outbreak, the Mayo Clinic Alzheimer’s Disease Research Center executive team has suspended all in-person research visits and outreach activities through May 31, 2020. This includes visits to Mayo Clinic for study exams, brain imaging, blood draws, and lumbar puncture procedures. It also includes all in-person educational and support programs and events through at least May 31, 2020.  If you are a research participant who also receives medical care at Mayo Clinic, those appointments will be managed by your healthcare provider on an individual basis. 

We will continue to monitor the situation and will provide updates on our research visits and outreach events as the COVID-19 situation evolves. We would like to thank you all for your dedication to dementia awareness and education, and for your support and commitment to dementia research.

If you are a Mayo Clinic ADRC study participant and have questions about your study visit, please call 904-953-6523.

Dr. Maisha Robinson awarded Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research Program Grant

January 13, 2020

Dr. Maisha Robinson

Congratulations to Mayo Clinic ADRC investigator, Dr. Maisha Robinson, for being one of 4 Mayo Clinic recipients of a Florida Moore grant. Her project: Between Here and There: Addressing End-of-Life Disparities Among African Americans with MCI and Dementia Through Community-Based Training in Advance Care Planning seeks to empower African American communities to ensure that the end-of-life wishes and preferences of community members with memory loss and dementia are made known, documented, and respected. Gov. Ron DeSantis announced the awards at a press conference on January 13.

The Ed & Ethel Moore grant program funds research seeking to improve the health of Floridians through better prevention, diagnosis, and treatment for Alzheimer’s disease and AD-related dementia. Congratulations are also in order for the three other Mayo ADRC investigators awarded Moore grants:

  • Dr Pamela McLean, Modeling Lewy body dementias: Towards a better understanding of amyloid-beta and alpha-synuclein in ADRDs.
  • Dr. Rickey Carter, Racial and Ethnic Differences in Gene Expression Data.
  • Dr. Pritam Das, Detection of vascular and inflammatory plasma biomarkers in patients diagnosed with obstructive sleep apnea and cerebral small vessel disease.

National Institutes of Health Receive Boost in Alzheimer’s Disease Funding

December 20, 2019

The US Senate has approved a $350 million increase in funding for the National Institutes of Health (NIH) to advance research on Alzheimer’s disease (AD) and AD-related dementia. This raises the total NIH budget for AD research to $2.8 billion for fiscal year 2020, recognizing the widespread public health crisis presented by this disease.
Over the last five years, advances in research have led to many discoveries, including new genes and pathways linked to the disease. The increased funding will help keep momentum going towards the discovery of new and effective treatments.

AD cannot currently be cured and is considered the most expensive disease in the country, costing taxpayers $290 billion in 2019. More than 5 million Americans are currently living with the disease and an estimated 16 million more are providing unpaid care to loved ones with dementia. As noted by the Alzheimer’s Association, "we owe it to these individuals and the millions more who will be impacted in the coming years to leave no stone unturned so we can advance treatments and find a cure for this devastating disease."


October 18, 2019

Dr. Floyd Wills, Family Medicine physician and investigator in the Mayo Clinic Alzheimer's Disease Research Center, has been named a recipient of the inaugural "Community Health Heroes" award from Agape Family Health, a local non-profit organization whose mission is to make comprehensive healthcare services available to the entire Jacksonville community, regardless of race, national origin, gender, age or socioeconomic status.

Dr. Willis is recognized for his research in Alzheimer’s disease among African-Americans, as well as for his current partnership with Edward Waters College to examine the potential role of students from minority-serving institutions in providing health education to the surrounding community.